This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1982;7(2-3):203-4.

doi: 10.1007/BF00254549.

VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC)

P A Madrigal, G P Manga, I Palomero, R G Gomez

PMID: 6282485
DOI: 10.1007/BF00254549

VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC)

P A Madrigal et al. Cancer Chemother Pharmacol. 1982.

. 1982;7(2-3):203-4.

doi: 10.1007/BF00254549.

Authors

P A Madrigal, G P Manga, I Palomero, R G Gomez

PMID: 6282485
DOI: 10.1007/BF00254549

No abstract available

PubMed Disclaimer

Similar articles

Combination cis-platinum and etoposide in small-cell lung cancer.
Natale RB, Wittes RE. Natale RB, et al. Cancer Treat Rev. 1982 Jun;9 Suppl:91-4. doi: 10.1016/s0305-7372(82)80085-6. Cancer Treat Rev. 1982. PMID: 6290058 No abstract available.
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF. Nemati F, et al. Clin Cancer Res. 2000 May;6(5):2075-86. Clin Cancer Res. 2000. PMID: 10815935
Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Lopez JA, Mann J, Grapski RT, Nassif E, Vannicola P, Krikorian JG, Finkel H. Lopez JA, et al. Cancer Treat Rep. 1985 Apr;69(4):369-71. Cancer Treat Rep. 1985. PMID: 2986833
Etoposide (VP-16) in the treatment of lung cancer.
Pedersen AG, Hansen HH. Pedersen AG, et al. Cancer Treat Rev. 1983 Dec;10(4):245-64. doi: 10.1016/0305-7372(83)90013-0. Cancer Treat Rev. 1983. PMID: 6318994 Review. No abstract available.
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
Goldhirsch A, Joss R, Cavalli F, Sonntag RW, Ryssel HJ, Brunner KW. Goldhirsch A, et al. Dtsch Med Wochenschr. 1981 Aug 28;106(35):1105-9. doi: 10.1055/s-2008-1070465. Dtsch Med Wochenschr. 1981. PMID: 6266800 Review. German. No abstract available.

See all similar articles

Cited by

Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Collins C, Higano CS, Livingston RB, Griffin BR, Keppen MD, Miller TP. Collins C, et al. Cancer Chemother Pharmacol. 1989;24(2):128-32. doi: 10.1007/BF00263134. Cancer Chemother Pharmacol. 1989. PMID: 2543513
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.
Poirier JT, Gardner EE, Connis N, Moreira AL, de Stanchina E, Hann CL, Rudin CM. Poirier JT, et al. Oncogene. 2015 Nov 26;34(48):5869-78. doi: 10.1038/onc.2015.38. Epub 2015 Mar 9. Oncogene. 2015. PMID: 25746006 Free PMC article.
Does the substitution of cisplatin in a standard four drug regimen improve survival in small cell carcinoma of the lung? A comparison of two chemotherapy regimens.
Smith AP, Anderson G, Chappell G, Bowen DR. Smith AP, et al. Thorax. 1991 Mar;46(3):172-4. doi: 10.1136/thx.46.3.172. Thorax. 1991. PMID: 1851339 Free PMC article. Clinical Trial.

References

1. Cancer Treat Rep. 1977 May-Jun;61(3):333-42 - PubMed
1. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1599-603 - PubMed
1. Radiology. 1968 Apr;90(4):688-97 - PubMed
1. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1593-7 - PubMed
1. Cancer. 1978 May;41(5):1710-4 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information